Insurance holding company Globe Life (NYSE: GL) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 5.4% year on year to $1.56 billion. Its non-GAAP profit of $3.43 per share was 1.3% below analysts’ consensus estimates.

Is now the time to buy GL? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Globe Life delivered first quarter results that were generally consistent with Wall Street’s expectations, as revenue growth in both life and health insurance segments contributed to stable performance. Management pointed to continued strength in health premium revenue, up 13% year-on-year, and highlighted the company’s ability to generate double-digit growth in net operating income per share in seven of the last eight quarters. CEO Frank Svoboda emphasized the resilience of Globe Life’s business model, noting, “Despite the challenges faced by working class Americans in the current economic environment, Globe Life has produced robust results.”

Looking ahead, Globe Life’s guidance is shaped by anticipated premium growth across both life and health businesses, strategic investments in technology, and the expanded use of artificial intelligence to enhance efficiency. Management believes that these factors will help lower administrative expenses and support margin expansion over the coming years. CFO Thomas Kalmbach stated, “We expect recent investments in AI and technology to drive a gradual decline in our expense ratio, contributing to improved profitability.” The company also expects continued benefits from favorable mortality trends and assumption updates, especially in the third quarter.

Key Insights from Management’s Remarks

Management attributed the quarter’s results to strength in health insurance premiums, agent productivity gains, and ongoing investments in technology and lead generation.

• Health premium momentum: The health segment saw solid growth, with premium revenue up 13% year-over-year, driven by rate increases in Medicare supplement products and robust sales in both United American and Family Heritage divisions. Management expects these tailwinds to persist throughout the year.

• Agent productivity initiatives: Management noted improvements in agent productivity, particularly within the American Income division, despite short-term declines in agent count. Compensation adjustments aimed at new agent recruiting and retention are expected to support agent count growth in the second half of the year.

• Direct-to-consumer channel evolution: The direct-to-consumer division continues to increase sales and margins by generating more high-quality leads, which are then shared with agency channels for higher conversion. Investments in advertising and lead generation are expected to drive incremental growth across multiple sales channels.

• AI-driven efficiency gains: Leadership highlighted expanded implementation of artificial intelligence initiatives across underwriting, distribution, and administrative functions. Management anticipates that AI will lower administrative expenses over time and enhance overall productivity.

• Share repurchase strategy: The company accelerated share buybacks in the first quarter, taking advantage of favorable market conditions. Management reiterated its intention to prioritize share repurchases as the primary use of excess cash, following payment of shareholder dividends.

Drivers of Future Performance

Management anticipates that health premium growth, technology investments, and assumption updates will shape performance for the rest of the year.

• Sustained health premium growth: Globe Life expects continued strength in health insurance premiums as approved rate increases and Medicare supplement sales drive top-line momentum. Management projects that these trends will support underwriting margins, particularly in the second and third quarters as the impact of premium increases is realized.

• AI and productivity enhancements: The company plans to expand AI applications to streamline administrative functions and agent onboarding, aiming to gradually reduce the expense ratio. Management believes that these efficiency gains will contribute to margin expansion over the next several years.

• Assumption updates and mortality trends: Upcoming assumption updates, particularly in the third quarter, are expected to provide a temporary boost to life underwriting margins. Management also anticipates that ongoing favorable mortality trends will support higher normalized margins and long-term earnings stability.

Catalysts in Upcoming Quarters

In future quarters, our analysts will be watching (1) the pace of agent count recovery, particularly at American Income, following compensation changes; (2) the realization of anticipated administrative expense savings as AI initiatives scale; and (3) the effect of Medicare supplement rate increases on health underwriting margins. Progress on these fronts, as well as sustained favorable mortality trends, will be key signposts for execution against Globe Life’s strategic objectives.

Globe Life currently trades at $151.02, in line with $151.25 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).

High Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.